Public University Corporation Yokohama City University
发明人:
申请号：
EP16855381.6
公开号：
EP3364188A4
申请日:
2016.10.11
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
Disclosed is a means whereby the efficacy of a pharmacotherapy drug for kidney cancer can be easily determined by a blood test. A method of assisting the evaluation of the effect of a drug therapy for the treatment of kidney cancer according to the present invention comprises measuring the PARK7 level in a blood sample taken from a patient with kidney cancer who receives the drug therapy for the treatment of kidney cancer. An increased PARK7 level indicates that the drug therapy is not effective. Moreover, by using the blood PARK7 level as an indicator, the efficacy of a candidate substance for a therapeutic agent for kidney cancer can also be determined.
